- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07573540
Optimizing Smart Technology for Addiction Recovery (STAR)
June 22, 2026 updated by: University of Wisconsin, Madison
Optimizing Algorithmic Feedback About Lapse Risk for Trust, Engagement, and Clinical Outcomes for Alcohol Use Disorder
The goal of this study is to develop a machine-learning guided recovery messaging system. The main question it aims to answer is can messages be used to:
- help people to improve their health
- make changes in people's lives to address alcohol and substance use
Participants will:
- complete surveys
- use a recovery-support digital therapeutic system
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study seeks to optimize messaging components which can be implemented in a recovery support messaging system such as may accompany a digital therapeutic app, in order to determine optimal messaging to increase interaction with recovery support resources, and whether messaging has any effect on clinical outcomes.
Study Type
Interventional
Enrollment (Estimated)
416
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Susan Wanta
- Phone Number: 608-262-0387
- Email: schneck2@wisc.edu
Study Contact Backup
- Name: Thea Blum
- Phone Number: 608-262-1362
- Email: tblm4@wisc.edu
Study Locations
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53706
- Recruiting
- University of Wisconsin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- meet criteria for alcohol use disorder with at least moderate severity (>= 4 DSM-5 criteria)
- in initial remission with most recent use of alcohol between 1 week and 3 months in the past
- able to read English
- have a smartphone and cellular plan that supports STAR use (Apple iOS or Android)
Exclusion Criteria:
- medical or psychiatric co-morbidities that preclude use of a smartphone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: STAR
Participants will use the STAR automated recover support system for 4 months
|
Automated recovery support messaging system for participants with alcohol use disorder (AUD), paired with a machine learning guided relapse risk prediction model.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Participant engagement with the STAR system
Time Frame: data collected at 2 and 4 months
|
Measured as days of engagement with the recovery system.
|
data collected at 2 and 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of heavy drinking days in the previous 28 days
Time Frame: data collected at baseline, 2, 4 months
|
Data collected via Timeline Followback (TLFB) conducted by interview at 0, 2, and 4 months.
Ecological Momentary Assessment (EMA) lapse reports will be used to supplement the TLFB.
These are daily surveys where the participant answers the question "have you had a drink you have not yet reported?"
(Yes/No).
If yes they are asked to indicate the date of their drinking and how many drinks they consumed that day (less than 1, 1-2, 3, 4, 5-6, 7-8, over 8).
Four or more drinks are considered heavy drinking days for women and greater than 4 drinks are considered heavy drinking days for men.
|
data collected at baseline, 2, 4 months
|
|
Number of drinking days in the previous 28 days
Time Frame: data collected at baseline, 2, 4 months
|
Data collected via Timeline Followback (TLFB) conducted by interview at 0, 2, and 4 months.
EMA lapse reports will be used to supplement the TLFB.
These are daily surveys where the participant answers the question "have you had a drink you have not yet reported?"
(Yes/No).
If yes, they are asked to indicate the date of their drinking.
|
data collected at baseline, 2, 4 months
|
|
Flourishing Scale Score
Time Frame: data collected at baseline, 2, 4 months
|
10 items rated on 0-10 Likert scale where lower scores represent worse functioning and higher scores represent better functioning.
Total possible range of scores is from 0-100.
|
data collected at baseline, 2, 4 months
|
|
Generalized Anxiety Disorder-7 (GAD-7) Score
Time Frame: data collected at baseline, 2, 4 months
|
7 items rated on 0-3 Likert scale where lower scores represent better functioning and higher scores represent worse functioning.
Total possible range of scores is from 0-21.
|
data collected at baseline, 2, 4 months
|
|
Multidimensional Inventory of Recovery Capital (MIRC) Score: Total Score
Time Frame: data collected at baseline, 2, 4 months
|
1-4 Likert scale.
Some items are reverse coded but higher total scores represent better functioning and lower total scores represent worse functioning.
Scored as total score 4-56.
|
data collected at baseline, 2, 4 months
|
|
Multidimensional Inventory of Recovery Capital (MIRC) Score: Each Domain
Time Frame: data collected at baseline, 2, 4 months
|
1-4 Likert scale.
Some items are reverse coded but higher total scores represent better functioning and lower total scores represent worse functioning.
Scored in 4 domains (social, physical, human, and cultural), each from 1-14.
|
data collected at baseline, 2, 4 months
|
|
Patient Health Questionnaire (PQH-9) Score
Time Frame: data collected at baseline, 2, 4 months
|
9 items rated on 1-4 Likert scale.
Total possible range of scores from 0-27 where lower scores represent better functioning and higher scores represent worse functioning.
|
data collected at baseline, 2, 4 months
|
|
Digital Working Alliance Inventory (D-WAI)
Time Frame: data collected at 2 and 4 months
|
Six items rated on 1-7 Likert scale.
Scored in 3 domains (Goals, Tasks, Bonds, each with 2 items) with possible scores from 2 to 14 where higher scores represent greater alliance with the STAR system in that domain.
|
data collected at 2 and 4 months
|
|
Message Usefulness
Time Frame: data collected at 2 and 4 months
|
Seven items rated on 1-7 Likert scale.
Total possible scores from 7 to 49 where higher scores represent greater valuation of STAR message usefulness.
|
data collected at 2 and 4 months
|
|
Trust of the System
Time Frame: data collected at 2 and 4 months
|
Ten items rated on 1-7 Likert scale.
Total possible scores from 10 to 70 where higher scores represent greater trust in the STAR system.
|
data collected at 2 and 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: John Curtin, PhD, University of Wisconsin, Madison
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 24, 2025
Primary Completion (Estimated)
January 31, 2029
Study Completion (Estimated)
July 31, 2029
Study Registration Dates
First Submitted
April 30, 2026
First Submitted That Met QC Criteria
April 30, 2026
First Posted (Actual)
May 7, 2026
Study Record Updates
Last Update Posted (Actual)
June 25, 2026
Last Update Submitted That Met QC Criteria
June 22, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024-0869
- A487400 (Other Identifier: UW Madison)
- 1R01AA031762-01 (U.S. NIH Grant/Contract)
- Protocol Version 4/22/2026 (Other Identifier: UW Madison)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Methamphetamine-dependence | Substance Use Disorders | Cocaine Use Disorder | Alcohol Use Disorder (AUD) | Cannabis Use Disorder | Amphetamine Use DisorderGermany
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
University of BernRecruitingAlcohol Use Disorder (AUD) | Substance Use Disorder (SUD) | Cocaine Use Disorder (CUD)Switzerland
-
Indiana UniversityPatient-Centered Outcomes Research InstituteRecruitingAdolescent | Alcohol Use | Mild Alcohol Use Disorder | Mild Substance Use DisorderUnited States
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
-
ITAB - Institute for Advanced Biomedical TechnologiesNot yet recruitingNeurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use DisorderAlcohol Dependence | Alcohol-Related Disorders | Substance Use Disorders | Drug Abuse | Mental Disorder | Alcohol Abuse | Alcohol Use Disorder (AUD)
-
Technische Universität DresdenCharite University, Berlin, Germany; Central Institute of Mental Health, MannheimRecruitingAlcoholism | Substance Use Disorders | Alcohol Use Disorder (AUD)Germany
Clinical Trials on STAR
-
UMC UtrechtDutch Heart FoundationNot yet recruitingHeart Failure NYHA Class II | Heart Failure NYHA Class III
-
University of California, San FranciscoSan Francisco Department of Public Health; San Francisco General Hospital; Sonoma...CompletedType 2 Diabetes Mellitus | Gestational Diabetes MellitusUnited States
-
Stryker Trauma GmbHCompleted
-
University Hospital Inselspital, BerneCompletedChronic Pelvic Pain SyndromeSwitzerland
-
University of WashingtonNational Institute on Aging (NIA); Kaiser PermanenteCompletedBehavioral Symptoms | Dementia | Alzheimer Disease | Caregiver BurdenUnited States
-
Encore Medical, L.P.CompletedOsteoarthritis | Rheumatoid Arthritis | Post Traumatic Arthritis | Primary ArthrosisUnited States
-
University of WashingtonAlzheimer's AssociationCompletedDementia | Alzheimer DiseaseUnited States
-
University Hospital Inselspital, BerneCompletedChronic Pelvic Pain SyndromeSwitzerland
-
Miulli General HospitalActive, not recruiting
-
University of New MexicoCompletedSimulator-based Training of Ultrasound-guided Regional AnesthesiaUnited States